BG100367A - The use of esters of n-alkylated, 1,4-dihydropyrimidinedicarboxylic acids as medicamentous forms - Google Patents

The use of esters of n-alkylated, 1,4-dihydropyrimidinedicarboxylic acids as medicamentous forms

Info

Publication number
BG100367A
BG100367A BG100367A BG10036796A BG100367A BG 100367 A BG100367 A BG 100367A BG 100367 A BG100367 A BG 100367A BG 10036796 A BG10036796 A BG 10036796A BG 100367 A BG100367 A BG 100367A
Authority
BG
Bulgaria
Prior art keywords
esters
alkylated
acids
dihydropyrimidinedicarboxylic
medicamentous forms
Prior art date
Application number
BG100367A
Other languages
Bulgarian (bg)
English (en)
Inventor
Siegfried Zaiss
Dieter Neuser
Johannes-Peter Stasch
Siegfried Goldmann
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG100367A publication Critical patent/BG100367A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG100367A 1993-08-27 1996-02-19 The use of esters of n-alkylated, 1,4-dihydropyrimidinedicarboxylic acids as medicamentous forms BG100367A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4328884A DE4328884A1 (de) 1993-08-27 1993-08-27 Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel
PCT/EP1994/002723 WO1995005823A1 (de) 1993-08-27 1994-08-16 Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsäureestern als arzneimittel

Publications (1)

Publication Number Publication Date
BG100367A true BG100367A (en) 1996-07-31

Family

ID=6496196

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100367A BG100367A (en) 1993-08-27 1996-02-19 The use of esters of n-alkylated, 1,4-dihydropyrimidinedicarboxylic acids as medicamentous forms

Country Status (13)

Country Link
EP (1) EP0714301A1 (cs)
JP (1) JPH09501923A (cs)
KR (1) KR960703594A (cs)
CN (1) CN1129906A (cs)
AU (1) AU7613594A (cs)
BG (1) BG100367A (cs)
CA (1) CA2170285A1 (cs)
CZ (1) CZ43896A3 (cs)
DE (1) DE4328884A1 (cs)
HU (1) HUT75302A (cs)
NO (1) NO960777L (cs)
PL (1) PL313116A1 (cs)
WO (1) WO1995005823A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741694C2 (de) * 1997-09-18 2002-10-31 Schering Ag Verwendung von Komplexen, deren Ligand ein Bis-Amin-Oxim-Derivat oder ein N¶2¶S¶2¶-Derivat und deren Zentralatom ein Radionuklid ist
CA2470813A1 (en) * 2001-12-20 2003-07-03 Bayer Healthcare Ag 1,4-dihydro-1,4-diphenylpyridine derivatives
US10258498B2 (en) * 2011-11-24 2019-04-16 Richter Gedeon Nyrt. 1,4-dihydropyridine derivatives with Hsp modulating activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
EP0169009A3 (en) * 1984-07-17 1988-08-31 FISONS plc Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PL313116A1 (en) 1996-06-10
CN1129906A (zh) 1996-08-28
JPH09501923A (ja) 1997-02-25
HUT75302A (en) 1997-05-28
EP0714301A1 (de) 1996-06-05
CA2170285A1 (en) 1995-03-02
DE4328884A1 (de) 1995-03-02
CZ43896A3 (en) 1996-05-15
NO960777L (no) 1996-04-10
WO1995005823A1 (de) 1995-03-02
KR960703594A (ko) 1996-08-31
AU7613594A (en) 1995-03-21
NO960777D0 (no) 1996-02-26
HU9600472D0 (en) 1996-04-29

Similar Documents

Publication Publication Date Title
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
GB2288732B (en) Pharmaceutical compositions
HK1026144A1 (en) Aryl ureas for the treatment of inflammatory or immunomodulatory diseases.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
EP0625507A3 (en) Urea derivatives and their use as acat inhibitors
CA2120303A1 (en) Cyclic adhesion inhibitors
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ZA943744B (en) Therapeutic substituted guanidines
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
MY115211A (en) Novel amino acid derivatives, their preparation and use
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
MX9709910A (es) Compuestos que contienen arginina e imitaciones de arginina, su uso y composiciones que los contienen.
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
PL346143A1 (en) Tan-1057 derivatives
MY109060A (en) New derivatives of b-amino acids
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
BG100367A (en) The use of esters of n-alkylated, 1,4-dihydropyrimidinedicarboxylic acids as medicamentous forms
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
ATE157660T1 (de) Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
GR3022471T3 (en) Novel cardioprotective agents.
WO1990010006A3 (de) NEUE β-METHOXYACRYLATE, IHRE HERSTELLUNG UND VERWENDUNG
PT828483E (pt) Utilizacao de derivados de tropolona como inibidores da enzima inositol monofosfatase
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis